Advanced 'Flagship' Full-Day Program

US$2,081
NT$66,800 · you pay the hospital in NT$

Women: US$2,174 (NT$69,800). The price above is for men.

Book this checkup

Prefer to book it yourself? Call Sijhih Cathay General Hospital on (02)2648-2121 ext. 3501 or 3502 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

An executive-tier program with Coronary artery calcium score, Colonoscopy, Gastroscopy (upper GI endoscopy), Abdominal ultrasound and Carotid ultrasound and a 80-test panel, with a doctor's review at the end.

Takes
One day, no overnight
Sedation
Available
Bowel prep
Required
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Coronary artery calcium score

Calcified plaque in heart arteries; refines heart attack risk.

Colonoscopy

Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.

Gastroscopy (upper GI endoscopy)

Stomach and esophagus ulcers, inflammation and cancer.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Every test, in English

80 tests listed, 66 of them on our shared test list, so they line up against other hospitals' packages.

Vitals4
Blood Count1
Liver Function9
Kidney & Electrolytes3
Lipids & Cardiometabolic7
Glucose2
Thyroid & Endocrine4
Tumor Markers7
Infection Serology3
Urine & Stool1
Cardiac4
Pulmonary1
X-ray3
Ultrasound4
CT Imaging2
Endoscopy2
Women's Health3
Bone & Body Composition1
Eye3
ENT & Dental1
Consultation1
Show all 80 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Liver Function
AlbuminLiver function and nutrition status.
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AST (SGOT)Liver cell damage.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Lactate dehydrogenaseNon-specific tissue damage marker.
Total bilirubinJaundice, liver and bile problems.
Total proteinNutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CreatinineKidney function.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratioA calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterolProtective cholesterol level.
HomocysteineCardiovascular risk marker.
High-sensitivity CRPInflammation linked to heart disease risk.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4Thyroid hormone level.
T3Thyroid hormone level.
TSHThyroid function; the primary thyroid screening test.
Vitamin D (25-OH)Vitamin D deficiency; bone health.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Ovarian cancer marker.
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
NSESmall cell lung cancer and neuroendocrine tumor marker.
PSAProstate cancer marker.
SCC antigenSquamous cell cancer marker (cervix, lung, head and neck).
Infection Serology
Hepatitis B core antibodyPast or hidden hepatitis B exposure.
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Cardiac
Creatine kinaseMuscle and heart muscle damage.
EchocardiogramHeart structure, valves and pumping function.
Exercise stress ECGReduced blood flow to the heart during exertion.
Resting ECGHeart rhythm and signs of prior heart damage.
Pulmonary
Lung function testAsthma, COPD and lung capacity.
X-ray
Abdominal X-ray (KUB)Kidney stones and bowel abnormalities.
Chest X-rayLung, heart size and chest abnormalities.
Spine X-rayDegeneration and alignment of the spine.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Carotid ultrasoundPlaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasoundProstate size and abnormalities.
CT Imaging
Coronary artery calcium scoreCalcified plaque in heart arteries; refines heart attack risk.
CT (region not specified)A CT scan whose body region the provider did not specify; confirm before comparing.
Endoscopy
ColonoscopyColon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)Stomach and esophagus ulcers, inflammation and cancer.
Women's Health
HPV DNA testHigh-risk HPV strains that cause cervical cancer.
MammographyBreast cancer; the standard screen for women 40+.
Pap smearCervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Eye
Color visionColor vision deficiency.
Intraocular pressureGlaucoma.
Visual acuityVision sharpness.
ENT & Dental
Hearing testHearing loss.
Consultation
Physician consultation and report reviewA doctor explains your results and what to do next.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Liver Function
Albumin
Liver function and nutrition status.
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
AST (SGOT)
Liver cell damage.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Lactate dehydrogenase
Non-specific tissue damage marker.
Total bilirubin
Jaundice, liver and bile problems.
Total protein
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Creatinine
Kidney function.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratio
A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterol
Protective cholesterol level.
Homocysteine
Cardiovascular risk marker.
High-sensitivity CRP
Inflammation linked to heart disease risk.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4
Thyroid hormone level.
T3
Thyroid hormone level.
TSH
Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)
Vitamin D deficiency; bone health.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125
Ovarian cancer marker.
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
NSE
Small cell lung cancer and neuroendocrine tumor marker.
PSA
Prostate cancer marker.
SCC antigen
Squamous cell cancer marker (cervix, lung, head and neck).
Infection Serology
Hepatitis B core antibody
Past or hidden hepatitis B exposure.
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Cardiac
Creatine kinase
Muscle and heart muscle damage.
Echocardiogram
Heart structure, valves and pumping function.
Exercise stress ECG
Reduced blood flow to the heart during exertion.
Resting ECG
Heart rhythm and signs of prior heart damage.
Pulmonary
Lung function test
Asthma, COPD and lung capacity.
X-ray
Abdominal X-ray (KUB)
Kidney stones and bowel abnormalities.
Chest X-ray
Lung, heart size and chest abnormalities.
Spine X-ray
Degeneration and alignment of the spine.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Carotid ultrasound
Plaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasound
Prostate size and abnormalities.
CT Imaging
Coronary artery calcium score
Calcified plaque in heart arteries; refines heart attack risk.
CT (region not specified)
A CT scan whose body region the provider did not specify; confirm before comparing.
Endoscopy
Colonoscopy
Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)
Stomach and esophagus ulcers, inflammation and cancer.
Women's Health
HPV DNA test
High-risk HPV strains that cause cervical cancer.
Mammography
Breast cancer; the standard screen for women 40+.
Pap smear
Cervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Eye
Color vision
Color vision deficiency.
Intraocular pressure
Glaucoma.
Visual acuity
Vision sharpness.
ENT & Dental
Hearing test
Hearing loss.
Consultation
Physician consultation and report review
A doctor explains your results and what to do next.
Also listed: 2-hour postprandial glucose, 7-region MRI (brain, neck, cervical spine, thoracic spine, lumbar spine, upper abdomen, pelvis), Body fat percentage, EBV VCA-IgA antibody, Family medicine consultation, Hepatitis A IgG antibody, Low-residue meal for exam prep, MCHC (mean corpuscular hemoglobin concentration), Red cell distribution width (RDW), Rheumatoid factor (RA), Sedation (painless), Specific allergen panel (house dust mite, storage mite, pet/poultry dander, German cockroach, tomato, carrot, potato, kiwi, garlic, peanut, soybean, almond, salmon, cod, crab, shrimp, mussel, cow milk, goat milk, egg white, egg yolk, etc.; 40 items), Urine sediment microscopy, White blood cell count and differential (neutrophils, lymphocytes, monocytes, eosinophils, basophils).

Before you book

SedationAvailable
Bowel prepRequired
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Sijhih Cathay General Hospital Health Examination Center
Regional hospital
New Taipei · Xizhi

11 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • For these endoscopy-related all-day packages, the center requires advance payment by bank transfer before the visit.

    Source ↗ · checked 2026-09-20

  • For these endoscopy packages, the NT$1,300 prep payment (bowel-prep medication and low-residue meal) already sent to the patient is not refunded if the checkup is cancelled at the last minute for personal reasons.

    Source ↗ · checked 2026-09-20

  • For patients booking an endoscopy exam, the center requires an advance payment of NT$1,300 for the bowel-prep medication and low-residue meal.

    Source ↗ · checked 2026-09-20

  • The center accepts payment by bank transfer to its designated account.

    Source ↗ · checked 2026-09-20

  • Since January 1, 2026 (year 115), the health checkup center's service hours are Monday to Friday, 8:00 to 17:00.

    Source ↗ · checked 2026-09-20

Before and on the day
  • The center requires a family member to accompany patients having sedated endoscopy, and says they must not drive or ride a motorbike that day.

    Source ↗ · checked 2026-09-20

  • For the C-13 urea breath test for H. pylori, the center requires 2 hours of fasting beforehand.

    Source ↗ · checked 2026-09-20

  • The center limits its mammography add-on to patients aged 40 and above.

    Source ↗ · checked 2026-09-20

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
Lipoprotein(a)
US$17
NT$550
Female hormone panel (FSH, LH, E2)as listed: Female hormone panel (FSH, LH, prolactin)
US$24
NT$770
For women
EBV VCA-IgAas listed: EBV antibody
US$16
NT$500
CA 15-3as listed: CA 15-3 tumor marker
US$31
NT$1,000
For women
Rubella antibodyas listed: Rubella antibody screening
US$9
NT$300
For women
Hepatitis A antibodyas listed: Hepatitis A IgG antibody
US$12
NT$400
Hepatitis B surface antibody
US$12
NT$400
H. pylori stool antigenas listed: Non-invasive stool H. pylori antigen rapid test
US$15
NT$490
H. pylori urea breath testas listed: C-13 urea breath test for H. pylori (2-hour fast)
US$47
NT$1,500
requires 2 hours of fasting beforehand
Stool occult blood (FIT)as listed: Stool occult blood test (EIA)
US$5
NT$160
Kidney and bladder ultrasoundas listed: Kidney ultrasound (Wed/Thu only)
US$40
NT$1,300
only scheduled on Wednesdays and Thursdays
Liver elastography (FibroScan)as listed: Liver fibrosis ultrasound scan (elastography)
US$47
NT$1,500

Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$8,597–12,650 for a woman (62 of 63 tests) and US$8,632–12,373 for a man (59 of 60 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 4.2 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1.4 years of natural background radiation (about 3 mSv a year, US average).

Not counted: 7-region MRI (brain, neck, cervical spine, thoracic spine, lumbar spine, upper abdomen, pelvis); Specific allergen panel (house dust mite, storage mite, pet/poultry dander, German cockroach, tomato, carrot, potato, kiwi, garlic, peanut, soybean, almond, salmon, cod, crab, shrimp, mussel, cow milk, goat milk, egg white, egg yolk, etc.; 40 items). If it is an X-ray, CT or PET scan, the total is higher.

  • Abdominal X-ray (KUB) · about 0.7 mSv
  • Bone density (DXA) · about less than 0.01 mSv
  • Chest X-ray · about 0.1 mSv
  • Coronary artery calcium score · about 1.7 mSv
  • Mammography · about 0.28 mSv
  • Spine X-ray · about 1.4 mSv

Plus CT (region not specified), whose dose depends on the exam.

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 30 of these tests
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with colonoscopy every 10 years, to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years with high-risk HPV testing every 5 years, alone or combined with cytology, as an alternative to cytology alone. (2018; an update is in progress) · USPSTF ↗ Note: For women aged 21 to 29 the 2018 statement recommends cytology alone every 3 years, not HPV testing. A draft update posted December 10, 2024 proposes primary HPV testing every 5 years (clinician- or patient-collected) for ages 30 to 65, with cytology every 3 years or cotesting every 5 years as alternatives; not yet a final USPSTF recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults. (2022) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 19 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Exercise stress ECG

Usually needs a few hours without food, and no caffeine for longer beforehand; wear comfortable clothing and walking or running shoes.

Mention when booking: Ask the prescribing doctor before changing any heart medicine before the test; mention asthma and bring an inhaler if you use one.

Afterwards: You are usually monitored for 10 to 15 minutes afterward until your heart rate returns to normal.

Lung function test

Usually asks for no smoking for 24 hours, no heavy meals for at least 2 hours, and no alcohol for at least 4 hours beforehand; wear loose clothing.

Mention when booking: Mention a recent heart attack, stroke or surgery, a chest infection, heart problems or uncontrolled blood pressure; ask whether to bring or hold your usual inhaler.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Prostate ultrasound

Usually needs little or no preparation; an enema and antibiotics are mainly for a planned biopsy. A scan through the lower belly instead may need a full bladder.

Mention when booking: Mention aspirin or other blood thinners; if a biopsy is planned, the center may ask about pausing them, so ask the prescribing doctor before changing any medicine.

CT (region not specified)

Usually needs a few hours without food or drink beforehand, especially if contrast is planned. Loose clothing and no jewelry.

Mention when booking: Tell the center about kidney disease, contrast allergy, diabetes medicine and possible pregnancy; ask the prescribing doctor before changing any medicine.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Colonoscopy

Usually needs a clear-liquid diet the day before and a split-dose bowel-cleansing prep taken the evening before and morning of the exam; drinking extra fluids helps avoid dehydration.

Mention when booking: Tell the center about heart, kidney or lung disease, blood thinners, diabetes medicine, aspirin, arthritis medicine or iron; ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, operating machinery or signing legal documents for the rest of the day; someone should take you home.

Gastroscopy (upper GI endoscopy)

Usually needs about 8 hours without food or drink, including water, beforehand.

Mention when booking: Tell the center about heart or lung disease, aspirin, blood thinners, arthritis medicine, insulin or iron, and ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, machinery or legal documents that day; get a ride home. Contact a doctor for fever, trouble swallowing, chest or belly pain, or black stools; bleeding can start days later.

HPV DNA test

Usually needs no special preparation; if combined with a Pap test, avoiding sex, douching and vaginal products for 2 days beforehand is common.

Mention when booking: Tell the center if you are menstruating or had recent intercourse; the test can usually still be done.

Afterwards: Light spotting afterward is common and usually stops within a few hours.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Advanced 'Flagship' Full-Day Program
US$2,081
Book this checkup

If this isn't quite right

Other packages at Sijhih Cathay General Hospital

PackageTestsPrice
Basic Half-Day Program A41
US$109
NT$3,500
Value Program (Civil Servant)Civil-servant36
US$109
NT$3,500
Ideal Program (Civil Servant)Civil-servant40
US$140
NT$4,500
Deluxe Program (Civil Servant)Civil-servant51
US$249
NT$8,000
Basic Half-Day Program B53
US$255
NT$8,200
Basic 'Peace of Mind' Full-Day Program68
US$461
NT$14,800
Women US$517
Basic 'Gut Health' Full-Day Program62
US$467
NT$15,000
Women US$523
Prestige Program (Civil Servant)Civil-servant58
US$498
NT$16,000
Advanced 'Deluxe Classic' Full-Day Program80
US$1,090
NT$35,000
Women US$1,184
Advanced 'Pilot' Full-Day Program77
US$1,832
NT$58,800
Women US$1,925

All packages at Sijhih Cathay General Hospital Health Examination Center →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Brain · Cancer screening · Heart and blood vessels · Stomach and colon · All checkups in New Taipei · What a checkup costs in Taiwan